American Israeli Medical Association AIMA

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) November 6, 2011 -- The American Israeli Medical Association
(AIMA) recently announced it will hold its first, annual BioMedTech Conference at Los Angeles'
Skirball Cultural Center on Tuesday, November 15, 2011 from 6 p.m. - 10 p.m. According to Dr. Ben
Drillings, director of AIMA, the keynote speaker for the event will be world-renowned aerospace and
biomedical entrepreneur and philanthropist Alfred E. Mann, chairman and CEO of MannKind
Corporation. Mr. Mann has founded 17 companies over six decades including: Spectrolab, Heliotek,

MiniMed and Advanced Bionics and developed key health products such as pacemakers, cochlear
implants and insulin pumps. The topic of Mann's presentation will be "Creating a Medical Device
Enterprise."
The AIMA conference will be a major event featuring leading Israeli dignitaries and key scientists and
executives from Israel's thriving research and biomedical companies. Joining Mann are a bevy of
prestigious speakers: David Seigel, Consul General of Israel in Los Angeles; Jacob Offenberger M.D.,
President, AIMA; Dr. Zeev Feldman, Chairman, IMA-WF; and Dr. Ben Drillings, Director & Founder,

AIMA. Over 300 attendees are expected to attend to hear about Israel's leading BioMedTech
companies. Among those registered are investors, venture capitalists, professional firms, executives,
medical doctors, academicians and entrepreneurs.
Dr. Ben Drillings, director and founder of AIMA, notes, "Israel is a world-leading center for biomedical
technology and the #1 innovator of medical devices. In Israel, biomedical technology is a booming
industry leading the world in innovation. Israel has produced ten Nobel Prize winners with four Israeli
academics winning in the area of chemistry. The conference will introduce the Israeli BioMedTech

industry to the California business community."
According to the 2011 Life Science Industry Catalogue published by Israel's Ministry of Industry,
Trade and Labor, Israel rates #1 in the world for medical device patents per capita, #4 for BioPharma
patents, and #4 in Global Scientific activity for the number of scientific publications per citizen. As of
2010, there were over 1,100 BioMedTech companies operating in Israel. Of those, 41% have formed
during the last five years and 34% have already begun to generate revenue.

"I am asking everyone to come and see the innovation that is coming from Israel," says Dr. Drillings,
"because these innovations will help make humankind healthier and change the way healthcare is
provided."
The Skirball Cultural Center is located at 2701 Sepulveda Boulevard in Los Angeles. To register for the
event, visit: www.aima4u.com. Email at: info@aima4u.com or call: (888) 991-1212.

American Israeli Medical Assoc